Loading...
Broad-Spectrum Antiviral Activities of Neplanocin A, 3-Deazaneplanocin A, and Their 5'-Nor Derivatives
de Clercq, Erik Cools, Marina Balzarini, Jan Marquez, Victor E. Borcherding, David R. Borchardt, Ronald T. Drach, John C. Kitaoka, Setsuko Konno, Tasuke
de Clercq, Erik
Cools, Marina
Balzarini, Jan
Marquez, Victor E.
Borcherding, David R.
Borchardt, Ronald T.
Drach, John C.
Kitaoka, Setsuko
Konno, Tasuke
Citations
Altmetric:
Abstract
The neplanocin A analogs, 3-deazaneplanocin A, 9-(trans-2',trans-3'-dihydroxycyclopent-4'-enyl)adenine (DHCA), and 9-(trans-2',trans-3'-dihydroxycyclopent-4'-enyl)-3-deazaadenine (DHCDA), all potent inhibitors of S-adenosylhomocysteine (AdoHcy) hydrolase, were studied for their broad-spectrum antiviral potential. 3-Deazaneplanocin A, DHCA, and DHCDA proved specifically effective against vesicular stomatitis virus, vaccinia virus, parainfluenza virus, reovirus, and rotavirus. Their selectivity was greater than that of neplanocin A, particularly against vesicular stomatitis virus and rotavirus. As could be expected from adenosine analogs that are directly targeted at AdoHcy hydrolase, 3-deazaneplanocin A, DHCA, and DHCDA were fully active in adenosine kinase-deficient cells, implying that their activity did not depend on phosphorylation by adenosine kinase. None of the AdoHcy hydrolase inhibitors showed selective activity against human immunodeficiency virus (type 1). 3-Deazaneplanocin A at a dose of 0.5 mg/kg per day conferred marked protection against a lethal infection of newborn mice with vesicular stomatitis virus.
Description
Date
1989-05-09
Journal Title
Journal ISSN
Volume Title
Publisher
The American Society for Microbiology
Files
Research Projects
Organizational Units
Journal Issue
Keywords
Citation
Clercq et al. "Broad-Spectrum Antiviral Activities of Neplanocin A, 3-Deazaneplanocin A, and Their 5'-Nor Derivatives."
Antimicrob. Agents Chemother. August 1989 vol. 33 no. 8 1291-1297.
http://dx.doi.org/10.1128/AAC.33.8.1291